**Question:** Which of the following antiglaucoma medications can cause drowsiness?

**Core Concept:** Antiglaucoma medications are drugs used to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. These medications can have various side effects, including systemic effects.

**Why the Correct Answer is Right:** Drowsiness is a side effect of certain antiglaucoma medications, especially those that have a significant systemic effect. In this case, the correct answer is:

**Correct Answer: C. Timolol**

Timolol is a beta-blocker that acts systemically to lower IOP. It blocks beta-1 and beta-2 receptors, which can lead to a range of side effects, including sedation and drowsiness.

**Why Each Wrong Option is Incorrect:** The other options (A, B, and D) represent different classes of antiglaucoma medications with varying degrees of systemic effects and side effects. These options can be eliminated based on the following reasoning:

**Option A (Brimonidine):** A selective alpha-2 adrenergic receptor agonist, brimonidine causes a decrease in aqueous humor production and outflow. It does not significantly affect beta-receptors, thus reducing the risk of drowsiness.

**Option B (Beta-blockers other than Timolol):** Beta-blockers other than Timolol, such as carteolol and propranolol, also block beta-1 and beta-2 receptors. However, they may cause less drowsiness due to a lower systemic availability, as they are usually used as topical drops for ocular applications.

**Option D (Alpha-agonists):** Alpha-agonists, like apraclonidine and phenylephrine, increase outflow of aqueous humor by enhancing the uveoscleral pathway. They do not cause sedation or drowsiness through systemic effects.

**Core Concept:** Drowsiness as a side effect is primarily associated with medications that have a significant systemic action. In contrast, the correct answer, Timolol, is a beta-blocker with a higher risk of causing drowsiness due to its systemic effects.

**Why Timolol is the correct answer:** Timolol is a beta-blocker with systemic effects, which can lead to drowsiness as a side effect. By contrast, the other options are either topical agents or have lower systemic availability, making drowsiness less likely.

**Clinical Pearls:**

1. It is essential for ophthalmologists to be aware of side effects of antiglaucoma medications, as they can impact patient adherence to treatment and quality of life.
2. Timolol is a beta-blocker with systemic effects, making it crucial to monitor patients for side effects like drowsiness, particularly in elderly patients with co-morbidities.